Preliminary genome screens are usually succeeded by fine mapping analyses focusing on the regions that signal linkage. It is advantageous to reduce the size of the regions where follow-up studies are performed, since this will help better tackle, among other things, the multiplicity adjustment issue associated with them. We describe a two-step approach that uses a confidence set inference procedure as a tool for intermediate mapping (between preliminary genome screening and fine mapping) to further localize disease loci. Apart from the usual Hardy-Weiberg and linkage equilibrium assumptions, the only other assumption of the proposed approach is that each region of interest houses at most one of the disease-contributing loci. Through a simulation study with several two-locus disease models, we demonstrate that our method can isolate the position of trait loci with high accuracy. Application of this two-step procedure to the data from the Arthritis Research Campaign National Repository also led to highly encouraging results. The method not only successfully localized a well-characterized trait contributing locus on chromosome 6, but also placed its position to narrower regions when compared to their LOD support interval counterparts based on the same data.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/gepi.20123 | DOI Listing |
Clin Chim Acta
December 2024
Unilabs Group, Geneva, Switzerland. Electronic address:
Background: Alternative means of blood sampling continue to grow due to the scarcity of phlebotomists and the need for person-centered care. It is crucial to consistently support these alternative blood sampling innovations with scientific evidence to guarantee the quality of care, especially when implementing for instance Lateral Upper-arm Blood Collection (LUBC) for non-trained professionals at home. Knowledge gaps remain in how to quantify imprecision introduced by the collection method and its impact on clinical use.
View Article and Find Full Text PDFJ Evid Based Med
December 2024
Research Center of Biliary Disease, West China Hospital, Sichuan University, Chengdu, China.
Background: Multiple and complicated hepatolithiasis can be associated with decompensated cirrhosis. Endoscopic retrograde cholangiopancreatography is unavailable for multiple and complicated hepatolithiasis, and the mainstay for decompensated cirrhosis is liver transplantation. However, due to the ethical factors and the complexity of operation, liver transplantation cannot be widely operated.
View Article and Find Full Text PDFInfect Control Hosp Epidemiol
December 2024
Infection Control and Prevention Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Objective: To upgrade cleaning and disinfection of patient rooms in a crowded emergency department (ED).
Setting: Tertiary referral hospital.
Design: Prospective, 3-component, before-and-after intervention study.
J Clin Neurosci
December 2024
Department of Neurosurgery, Second Hospital of Shanxi Medical University, Taiyuan, PR China. Electronic address:
Background: Intracranial aneurysms are the main cause of subarachnoid hemorrhage (SAH), a severe stroke with devastating effects. However, there are no existing medications for intracranial aneurysms (IAs) and novel therapeutic targets are required.
Methods: We performed a summary data-based Mendelian Randomization (MR) analysis to explore the causal association between circulating plasma proteins and the risk of IAs and SAH.
World Allergy Organ J
December 2024
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Background: Asthma is a global chronic respiratory disease with complex pathogenesis. While current therapies offer some relief, they often fall short in effectively managing symptoms and preventing exacerbations for numerous patients. Thus, understanding its mechanisms and discovering new drug targets remains a pressing need for better treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!